Vishal Manchanda is currently driven by Broad_market. The recent article tape shows 2 bullish, 1 bearish, and 0 neutral reads across 1 sources.
Updated 23 Jun 2026, 12:26 pm IST · Sentiment is computed from saved analyzed news and quote snapshots.
Vishal Manchanda has 3 recent analyzed stories in this hub, with a sector bias score of +42. The dominant cluster is Broad_market, and the story breadth is 2 bullish, 1 bearish, and 0 neutral reads.
The most repeated listed names are SUNPHARMA, NUVAMA, RADICO. These are the names drawing the most coverage; quote movement, volume, and company-specific context add further reference.
The Indian pharma sector is evolving from a generics-heavy model to one focused on innovation and higher-value products. This shift is crucial for sustained growth and margin expansion.
No negative stock cluster yet.
Economic Times · 23 days ago · 2 min read
Economic Times · 29 days ago · 2 min read
Economic Times · 29 days ago · 2 min read
Economic Times · 58 days ago · 2 min read
Mint · 63 days ago · 2 min read
Vishal Manchanda coverage is leaning bullish across 3 recent stories from 1 sources. The article split is 2 bullish, 1 bearish, and 0 neutral.
The strongest article-driven stock reads in this hub are SUNPHARMA (+69), NUVAMA (+39), RADICO (+39). These scores are based on saved article impact, not a standalone buy signal.
No clear negative stock cluster is available for Vishal Manchanda yet.
Recent Vishal Manchanda coverage is clustering around Broad_market, Consumer Staples, Financial Services.